|
End-of-day quote
Dhaka S.E.
2026-11-17
|
5-day change | 1st Jan Change | ||
| 25.20 BDT | -0.40% |
|
+2.02% | -8.03% |
| Market Cap | 6.69B 53.57M 48.63M 44.92M 40.53M 76.51M 5.01B 79.44M 541M 214M 2.7B 201M 197M 8.53B | P/E 2024 |
50.8x | P/E 2025 | -17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 32.23B 258M 234M 216M 195M 368M 24.1B 383M 2.61B 1.03B 13.01B 968M 948M 41.1B | EV / Sales 2024 |
3.62x | EV / Sales 2025 | 7.99x |
| Free-Float |
74.17% | Yield 2024 |
1.45% | Yield 2025 | - |
| 1 day | -0.40% | ||
| 1 week | +2.02% | ||
| Current month | -10.95% | ||
| 1 month | -13.40% | ||
| 3 months | -11.27% | ||
| 6 months | -1.95% | ||
| Current year | -8.03% |
| 1 week | 24.7 | 26.1 | |
| 1 month | 23.6 | 30.3 | |
| Current year | 23.5 | 33.2 | |
| 1 year | 23.5 | 33.2 | |
| 3 years | 22.9 | 91.8 | |
| 5 years | 22.9 | 156.5 | |
| 10 years | 22.9 | 156.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zareen Karim
CEO | Chief Executive Officer | 48 | 2019-12-31 |
| Director of Finance/CFO | - | - | |
| Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2014-09-09 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1984-12-31 |
Hasina Begum
BRD | Director/Board Member | 68 | 1996-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.40% | +2.02% | +1.61% | -68.34% | 47.54M | ||
| -1.13% | +0.25% | +38.06% | +140.43% | 1,275B | ||
| -1.36% | -1.21% | +42.24% | +85.68% | 680B | ||
| -0.59% | -0.16% | +26.02% | +111.76% | 521B | ||
| -0.76% | +1.27% | +41.98% | +71.50% | 389B | ||
| -0.75% | -3.62% | +54.29% | +40.57% | 356B | ||
| -1.83% | -0.13% | +27.64% | +60.13% | 305B | ||
| -1.65% | -1.88% | +2.00% | +35.77% | 287B | ||
| -0.95% | -1.57% | +35.99% | +70.23% | 250B | ||
| +1.60% | +0.56% | +36.19% | +128.48% | 208B | ||
| Average | -0.55% | +0.19% | +30.60% | +67.62% | 427B | |
| Weighted average by Cap. | -0.64% | +0.76% | +35.59% | +96.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.62B 85.01M 77.18M 71.29M 64.32M 121M 7.94B 126M 859M 340M 4.29B 319M 312M 13.54B | 4.08B 32.67M 29.66M 27.4M 24.72M 46.66M 3.05B 48.45M 330M 131M 1.65B 123M 120M 5.2B |
| Net income | 318M 2.55M 2.31M 2.14M 1.93M 3.64M 238M 3.78M 25.73M 10.18M 128M 9.55M 9.35M 406M | -415M -3.32M -3.02M -2.79M -2.51M -4.75M -311M -4.93M -33.59M -13.29M -168M -12.47M -12.21M -530M |
| Net Debt | 22.31B 179M 162M 150M 135M 255M 16.68B 265M 1.8B 714M 9B 670M 656M 28.44B | 25.54B 204M 186M 171M 155M 292M 19.1B 303M 2.07B 817M 10.31B 767M 751M 32.56B |
Employees
2,954
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-17 | BDT 25.20 | -0.40% | 353,662 |
| 26-11-16 | BDT 25.30 | +1.61% | 193,127 |
| 26-11-15 | BDT 24.90 | -0.80% | 312,453 |
| 26-11-12 | BDT 25.10 | -3.09% | 433,555 |
| 26-11-11 | BDT 25.90 | +3.19% | 326,256 |
- Stock Market
- Stocks
- ORIONPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
















